CARIS LIFE SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CARIS LIFE SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 173.17K shares.
- CARIS LIFE SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 136.10K shares.
- CARIS LIFE SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 478.10K shares.
- CARIS LIFE SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 601.04K shares.
- CARIS LIFE SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.77M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 173.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 1.39M shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 136.10K shares 10-Q · filed 2026-05-08 | |
| 2025-12-31 | 478.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 1.77M shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 601.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |